Akari Therapeutics, Plc (AKTX) Ownership
AKTX ownership summary
as of October 18, 2026- Institutions
- 10.5% of shares outstanding
- Insiders
- 13.25% of shares outstanding
- Shares outstanding
- 2.3M
- Float
- 1.3M shares available to trade
- Short interest
- 1.15% 15K shares short
- Days to cover
- 0.18 short interest up 35.0% vs prior month
- Institutions 10.52%
- Insiders 13.25%
- Other investors 76.23%
AKTX top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Mmcap International Inc. Spc | 4.38% | 100K | $818,000 | +100,000 (0.0%) | June 30, 2026 |
| 2 | Cresset Asset Management, LLC | 0.90% | 21K | $168,189 | — | June 30, 2026 |
| 3 | Jane Street Group LLC | 0.68% | 15K | $126,487 | +15,463 (0.0%) | June 30, 2026 |
| 4 | HRT FINANCIAL LLC | 0.60% | 14K | $112,434 | +13,745 (0.0%) | June 30, 2026 |
| 5 | IFP Advisors, LLC | 0.01% | 181 | $1,481 | — | June 30, 2026 |
| 6 | SBI Securities Co Ltd | <0.01% | 14 | $115 | +9 (+180.0%) | June 30, 2026 |
| 7 | Caitong International Asset Management Co., Limited. | <0.01% | 8 | $65 | +8 (0.0%) | June 30, 2026 |
| 8 | Northwestern Mutual Wealth Management Co | <0.01% | 7 | $57 | +7 (0.0%) | June 30, 2026 |
| 9 | Truvestments Capital LLC | 0.00% | 1 | $8 | — | June 30, 2026 |
| 10 | Palo Alto Investors, LLC | 0.00% | — | — | −146,024 (−100.0%) | March 31, 2026 |
| 11 | CWA Asset Management Group, LLC | 0.00% | — | — | −55,000 (−100.0%) | March 31, 2026 |
| 12 | Independent Advisor Alliance | 0.00% | — | — | −17,075 (−100.0%) | March 31, 2026 |
| 13 | Warberg Asset Management LLC | 0.00% | — | — | −308,340 (−100.0%) | March 31, 2026 |
| 14 | Goss Wealth Management LLC | 0.00% | — | — | −170 (−100.0%) | March 31, 2026 |
| 15 | HighTower Advisors, LLC | 0.00% | — | — | −79,236 (−100.0%) | March 31, 2026 |
| 16 | SmartHarvest Portfolios, LLC | 0.00% | — | — | −69,248 (−100.0%) | March 31, 2026 |
| 17 | UBS Group AG | 0.00% | — | — | −32,855 (−100.0%) | March 31, 2026 |
| 18 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −1 (−100.0%) | June 30, 2026 |
| 19 | Cornerstone Planning Group LLC | 0.00% | — | — | −5 (−100.0%) | March 31, 2026 |
| 20 | Accent Capital Management LLC | 0.00% | — | — | −5,000 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 6 holders added 129K shares and 11 cut 713K.
AKTX top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | LUX IM Global Medtech HX | 0.00% | 1 | $8 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
AKTX insider transactions
latest 6| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-25 | Abizer Gaslightwala | Buy | $36.00 | 75 | $2,700 |
| 2025-08-22 | Abizer Gaslightwala | Buy | $37.20 | 200 | $7,440 |
| 2025-08-21 | Abizer Gaslightwala | Buy | $37.60 | 250 | $9,400 |
| 2025-06-24 | Abizer Gaslightwala | Buy | $46.40 | 130 | $6,032 |
| 2025-06-23 | Abizer Gaslightwala | Buy | $46.00 | 23 | $1,058 |
| 2025-06-20 | Abizer Gaslightwala | Buy | $48.00 | 250 | $12,000 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
AKTX shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AKTX
Institutional investors own 10.5% of Akari Therapeutics, Plc's shares and insiders 13.25%. The largest holder is Mmcap International Inc. Spc with 4.38% of the shares (100K), as of June 30, 2026. Among the top 20 institutions, 6 added shares and 11 reduced their stake in the latest filings. Short interest is 1.15% of the float, or 0.18 days of average trading volume. The share count rose 6,900.0% since 2015.
Related: AKTX analyst forecast, AKTX key metrics. See the AKTX stock overview for the latest quote and news.
AKTX ownership FAQ
Who owns the most Akari Therapeutics, Plc stock?
The largest shareholders of Akari Therapeutics, Plc are Mmcap International Inc. Spc (4.38%), Cresset Asset Management, LLC (0.90%), Jane Street Group LLC (0.68%), HRT FINANCIAL LLC (0.60%), IFP Advisors, LLC (0.01%).
What percentage of Akari Therapeutics, Plc is owned by institutions?
Institutions hold 10.5% of Akari Therapeutics, Plc's shares outstanding; insiders hold 13.25%.
Which funds own Akari Therapeutics, Plc?
The largest fund holders of Akari Therapeutics, Plc are LUX IM Global Medtech HX (0.00%).
What is Akari Therapeutics, Plc's short interest?
15K shares of Akari Therapeutics, Plc were sold short, 1.15% of the float; at the average daily volume it would take 0.18 days to cover.
Are insiders buying or selling Akari Therapeutics, Plc?
Of the latest 6 reported insider transactions in Akari Therapeutics, Plc (since June 20, 2025), 6 were purchases and 0 were sales.
How many shares of Akari Therapeutics, Plc are outstanding?
Akari Therapeutics, Plc has 2.3M shares outstanding, of which 1.3M are in the public float.